Prevention: some important steps forward, but many unmet needs in a world with cardiovascular disease as the leading cause of death

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1

(2016) Hans-Christoph Diener et al.   EUROPEAN HEART JOURNAL

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2

(2016) Hans-Christoph Diener et al.   EUROPEAN HEART JOURNAL

An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)

(2016) Colin D. Bicknell et al.   EUROPEAN HEART JOURNAL

The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?

(2016) John A. Cairns   EUROPEAN HEART JOURNAL

Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry

(2016) Carolyn S.P. Lam et al.   EUROPEAN HEART JOURNAL

Sodium–glucose co-transporter-2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus: the road ahead

(2016) Caroline K. Kramer et al.   EUROPEAN HEART JOURNAL

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus

(2016) Nikolaus Marx et al.   EUROPEAN HEART JOURNAL

Cardiovascular disease in Europe: epidemiological update 2016

(2016) Nick Townsend et al.   EUROPEAN HEART JOURNAL

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest

(2015) Carole Maupain et al.   EUROPEAN HEART JOURNAL

Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission—not reliable enough to be true!

(2015) Kjetil Sunde et al.   EUROPEAN HEART JOURNAL

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

(2015) Giuseppe Mancia et al.   EUROPEAN HEART JOURNAL

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes

(2015) Ele Ferrannini et al.   EUROPEAN HEART JOURNAL

Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study

(2015) Sune Fallgaard Nielsen et al.   EUROPEAN HEART JOURNAL

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

(2015) Jennifer B. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

(2013) Benjamin M. Scirica et al.   NEW ENGLAND JOURNAL OF MEDICINE